| LUXEMBOURG | WP4 | |||
| Organization | LIH | |||
| Name of cohort | NCER-PD | |||
| Referring partner | LIH | |||
| Cohort Information | Country(-ies), cities, regions or centers involved | Luxembourg | ||
| Time of data collection | 06/2015 | 07/2023 | ||
| Enrolment | Inactive | |||
| Study setting | Single center | |||
| Population | Age | Adults,Elderly | ||
| Type | Prospective | |||
| Total number of patients | 154 | |||
| Type of frailty (WP4) | Parkinson | |||
| Data collection | Clinical data | True | ||
| Serological data | True | |||
| Genetic data | False | |||
| Sample collection | True | |||
| Sample collected | Whole blood | Yes | ||
| PBMC | No | |||
| Dry-spot blood | No | |||
| Plasma | No | |||
| Serum | No | |||
| Stool | Yes | |||
| NP swabs | Yes | |||
| Other | None | |||
| Description | Participants of the Luxembourg Parkinson's study who have consented to be recontacted for scientifically relevant questions in the neurological field arise, as people with Parkinson's disease may have increased susceptibility to SARS-CoV-2 infection and potentially different immune responses and persistence after vaccination, along with both the psychological impact of the pandemic, particularly in an elderly population, will be invited to participate in ORCHESTRA Luxembourg as part of the fragile population (Arm B) | |||